Reply to J.B. Aragon-Ching and D. Dalela et al

Affiliations

Comment

Ana Aparicio et al. J Clin Oncol. 2017.

. 2017 Mar 10;35(8):917-918.

doi: 10.1200/JCO.2016.70.9238. Epub 2016 Dec 12.

¹ Ana Aparicio and Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX.

No abstract available

Comment on

Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer.
Rusthoven CG, Jones BL, Flaig TW, Crawford ED, Koshy M, Sher DJ, Mahmood U, Chen RC, Chapin BF, Kavanagh BD, Pugh TJ. Rusthoven CG, et al. J Clin Oncol. 2016 Aug 20;34(24):2835-42. doi: 10.1200/JCO.2016.67.4788. Epub 2016 Jun 20. J Clin Oncol. 2016. PMID: 27325855
Promises and Pitfalls of Primary Local Treatment in Metastatic Prostate Cancer.
Aragon-Ching JB. Aragon-Ching JB. J Clin Oncol. 2017 Mar 10;35(8):914. doi: 10.1200/JCO.2016.70.3520. Epub 2016 Dec 12. J Clin Oncol. 2017. PMID: 27937093 No abstract available.
Improved Survival With Local Treatment of Prostate Cancer in Men With Metastatic Disease: Look Before You Leap.
Dalela D, Jindal T, Menon M, Abdollah F. Dalela D, et al. J Clin Oncol. 2017 Mar 10;35(8):914-915. doi: 10.1200/JCO.2016.69.6617. Epub 2016 Dec 12. J Clin Oncol. 2017. PMID: 27937094 No abstract available.